HALOPERIDOL DECANOATE LA INJECTION DIN 02564386
Status: Approved
Holder: HIKMA CANADA LIMITED
Molecule: HALOPERIDOL (HALOPERIDOL DECANOATE)
Available to quote
Health Canada record
| Active ingredient(s) | HALOPERIDOL (HALOPERIDOL DECANOATE) 100 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N05AD01 HALOPERIDOL |
| Original market date | |
| Current status date | 09-Jan-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hikma Canada Limited — licence 3-002579, currently licensed, last inspection rating C (2026-06-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing HALOPERIDOL (HALOPERIDOL DECANOATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02383748 | HALOPERIDOL DECANOATE INJECTION | STRIDES PHARMA CANADA INC | Solution | HALOPERIDOL (HALOPERIDOL DECANOATE) 50 MG | Approved |
| 02383756 | HALOPERIDOL DECANOATE INJECTION | STRIDES PHARMA CANADA INC | Solution | HALOPERIDOL (HALOPERIDOL DECANOATE) 100 MG | Approved |
| 02564378 | HALOPERIDOL DECANOATE LA INJECTION | HIKMA CANADA LIMITED | Solution | HALOPERIDOL (HALOPERIDOL DECANOATE) 50 MG | Approved |
| 02130300 | HALOPERIDOL LA | SANDOZ CANADA INCORPORATED | Liquid | HALOPERIDOL (HALOPERIDOL DECANOATE) 100 MG | Marketed |
| 02242361 | APO-HALOPERIDOL LA INJECTABLE | APOTEX INC | Liquid | HALOPERIDOL (HALOPERIDOL DECANOATE) 50 MG | Cancelled Post Market |
| 02242362 | APO-HALOPERIDOL LA INJECTABLE | APOTEX INC | Liquid | HALOPERIDOL (HALOPERIDOL DECANOATE) 100 MG | Cancelled Post Market |
| 02099624 | HALOPERIDOL DECANOATE INJ. LIQ IM 100MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | HALOPERIDOL (HALOPERIDOL DECANOATE) 100 MG | Cancelled Post Market |
| 02099616 | HALOPERIDOL DECANOATE INJ. LIQ IM 50MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | HALOPERIDOL (HALOPERIDOL DECANOATE) 50 MG | Cancelled Post Market |
| 02194449 | HALOPERIDOL DECANOATE INJECTION | HOSPIRA HEALTHCARE ULC | Liquid | HALOPERIDOL (HALOPERIDOL DECANOATE) 100 MG | Cancelled Pre Market |
| 02194430 | HALOPERIDOL DECANOATE INJECTION | HOSPIRA HEALTHCARE ULC | Liquid | HALOPERIDOL (HALOPERIDOL DECANOATE) 50 MG | Cancelled Pre Market |
| 02130297 | HALOPERIDOL LA | SANDOZ CANADA INCORPORATED | Liquid | HALOPERIDOL (HALOPERIDOL DECANOATE) 50 MG | Cancelled Post Market |
| 02242631 | HALOPERIDOL LONG ACTING | NOVOPHARM LIMITED | Liquid | HALOPERIDOL (HALOPERIDOL DECANOATE) 100 MG | Cancelled Post Market |
| 02236866 | HALOPERIDOL LONG ACTING | NOVOPHARM LIMITED | Liquid | HALOPERIDOL (HALOPERIDOL DECANOATE) 50 MG | Cancelled Post Market |
| 02239640 | HALOPERIDOL-LA OMEGA | OMEGA LABORATORIES LIMITED | Liquid | HALOPERIDOL (HALOPERIDOL DECANOATE) 100 MG | Dormant |
| 02239639 | HALOPERIDOL-LA OMEGA | OMEGA LABORATORIES LIMITED | Liquid | HALOPERIDOL (HALOPERIDOL DECANOATE) 50 MG | Cancelled Post Market |
| 02230707 | PMS-HALOPERIDOL-LA | PHARMASCIENCE INC | Liquid | HALOPERIDOL (HALOPERIDOL DECANOATE) 50 MG | Cancelled Post Market |
| 02230708 | PMS-HALOPERIDOL-LA | PHARMASCIENCE INC | Liquid | HALOPERIDOL (HALOPERIDOL DECANOATE) 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36713 | 2026-01-09 | Abbreviated New Drug Submission (ANDS) |